Glaucoma management in adults: an update
- 1Austin Health, Melbourne
- 2Royal Victorian Eye and Ear Hospital, Melbourne
Abstract
SUMMARY: Glaucoma is a group of progressive optic neuropathies that cause optic nerve damage and visual field defects. It is typically asymptomatic until irreversible vision loss has occurred. Early detection relies on regular comprehensive eye examinations, with targeted case finding particularly important for people at increased risk.
Lowering intraocular pressure is the only proven strategy to slow disease progression, and treatment should be individualised. Topical prostaglandin analogues (eye drops) are commonly used as first-line medical therapy, with once-daily dosing associated with improved adherence. Topical beta blockers may be added if the target intraocular pressure is not achieved or disease progression occurs. Patient adherence, eye drop technique and adverse effects should be reviewed regularly.
Selective laser trabeculoplasty (a laser treatment that helps fluid drain out of the eye, thereby lowering intraocular pressure) is an effective first-line alternative to eye drops.
Urgent referral to an ophthalmologist or emergency department is required for a suspected acute angle-closure attack. Symptoms include severe eye pain, headache, blurred vision, halos around lights, nausea and vomiting.
Related
- Metaplasia intestinal gástrica: actualización en epidemiología, diagnóstico, estratificación del riesgo y manejo clínico Gastric Intestinal Metaplasia: an Update on Epidemiology, Diagnosis, Risk Stratification, and Clinical Management
- ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
- ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
- Cancer-related pain management update in 2025: refining established therapies and expanding toward integrated multimodal and longitudinal management.
- Real-world effectiveness and tolerability of fixed dose netarsudil/latanoprost in the management of patients with uncontrolled glaucoma
BibTeX
@article{loh2026glaucoma,
title = {{Glaucoma management in adults: an update}},
author = {Poh Wein Loh and Mark Walland and Alp Atik},
journal = {Australian Prescriber},
year = {2026},
month = oct,
doi = {10.18773/austprescr.2026.038},
url = {https://doi.org/10.18773/austprescr.2026.038},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Glaucoma management in adults: an update
AU - Poh Wein Loh
AU - Mark Walland
AU - Alp Atik
PY - 2026
DA - 2026/10/01
JO - Australian Prescriber
DO - 10.18773/austprescr.2026.038
UR - https://doi.org/10.18773/austprescr.2026.038
AB - SUMMARY: Glaucoma is a group of progressive optic neuropathies that cause optic nerve damage and visual field defects. It is typically asymptomatic until irreversible vision loss has occurred. Early detection relies on regular comprehensive eye examinations, with targeted case finding particularly important for people at increased risk. Lowering intraocular pressure is the only proven strategy to slow disease progression, and treatment should be individualised. Topical prostaglandin analogues (eye drops) are commonly used as first-line medical therapy, with once-daily dosing associated with improved adherence. Topical beta blockers may be added if the target intraocular pressure is not achieved or disease progression occurs. Patient adherence, eye drop technique and adverse effects should be reviewed regularly. Selective laser trabeculoplasty (a laser treatment that helps fluid drain out of the eye, thereby lowering intraocular pressure) is an effective first-line alternative to eye drops. Urgent referral to an ophthalmologist or emergency department is required for a suspected acute angle-closure attack. Symptoms include severe eye pain, headache, blurred vision, halos around lights, nausea and vomiting.
SN - 0312-8008
SN - 1839-3942
ER -